Wang Lei, Global Executive Vice President and President of International Business and China at AstraZeneca, stated that over the past five years, relying on the advantages of China's large market, CIIE has made positive contributions to accelerating the construction of a new development pattern and promoting world economic development. Through the CIIE, AstraZeneca deeply felt the signal of China's adherence to opening-up and continued support for economic globalization, as well as its responsible image as a major country.
Wang Lei stated that AstraZeneca, as an old friend of CIIE, has participated in six consecutive exhibitions this year. Relying on the strong influence and spillover effects of the CIIE platform, AstraZeneca will announce the latest progress in investment in China at this CIIE, continue to increase investment in China, including research and development, medical innovation, and promote production and supply layout. AstraZeneca will also work with cross-border partners to continuously assist Chinese enterprises and innovative achievements in accelerating their "going global" journey, creating a "global new" with "China's new" approach, promoting the sustainable development of healthcare and contributing to the cause of human health.
Wang Lei stated that history has proven that the Chinese economy is a very stable development ship, and China is one of the largest markets in the world. AstraZeneca will use a more determined belief to play a role as a link and bridge, deepening its long-term commitment to "rooted in China, serving China, and benefiting the world".